AMALGAMATED BANK – Neurocrine Biosciences, Inc. Transaction History
AMALGAMATED BANK portfolio value:
$7.82M
portfolio value
AMALGAMATED BANK quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +2.92% | 2.08K shares | 847K | $106.21 | 73.71K |
| Q2 2022 | share | Increase | +1.36% | 960 shares | 357K | $97.48 | 71.62K |
| Q1 2022 | share | Increase | +0.02% | 14 shares | 608K | $93.75 | 70.66K |
| Q4 2021 | share | Increase | +5.04% | 3.38K shares | -434K | $84.63 | 70.64K |
| Q3 2021 | share | Decrease | -9.48% | -7.04K shares | -780K | $95.91 | 67.25K |
| Q2 2021 | share | Increase | +329.10% | 56.98K shares | 5.54M | $97.32 | 74.30K |
| Q1 2021 | share | Decrease | -6.93% | -1.29K shares | -99K | $97.25 | 17.31K |
| Q4 2020 | share | Increase | +0.02% | 4 shares | -6K | $95.85 | 18.60K |
| Q3 2020 | share | Decrease | -2.51% | -478 shares | -539K | $96.16 | 18.60K |
| Q2 2020 | share | Decrease | -20.09% | -4.79K shares | 261K | $122 | 19.08K |
| Q1 2020 | share | Decrease | -1.55% | -375 shares | -540K | $86.55 | 23.87K |
| Q4 2019 | share | Increase | +6.46% | 1.47K shares | 554K | $107.49 | 24.25K |
| Q3 2019 | share | Increase | +13.95% | 2.78K shares | 365K | $90.11 | 22.78K |
| Q2 2019 | share | Decrease | -2.02% | -412 shares | -110K | $84.43 | 19.99K |
| Q1 2019 | share | Increase | +2.26% | 450 shares | 373K | $88.1 | 20.40K |
| Q4 2018 | share | Increase | +63.40% | 7.74K shares | -76K | $71.41 | 19.95K |
| Q3 2018 | share | Decrease | -41.35% | -8.61K shares | -545K | $122.95 | 12.21K |
| Q2 2018 | share | Increase | +10.10% | 1.91K shares | 478K | $98.24 | 20.82K |
| Q1 2018 | share | Increase | +8.17% | 1.42K shares | 211K | $82.93 | 18.91K |
| Q4 2017 | share | Increase | +5.73% | 947 shares | 344K | $77.59 | 17.48K |
| Q3 2017 | share | Increase | +2.39% | 386 shares | 270K | $61.28 | 16.53K |
| Q2 2017 | share | Increase | +28.70% | 3.60K shares | 200K | $46 | 16.15K |
| Q1 2017 | share | Decrease | -18.06% | -2.76K shares | -50K | $43.3 | 12.54K |
| Q4 2016 | share | Increase | +11.54% | 1.58K shares | -102K | $38.7 | 15.31K |
| Q3 2016 | share | Increase | +0.01% | 1 shares | 33K | $50.64 | 13.73K |
| Q2 2016 | share | Increase | +52.65% | 4.73K shares | 306K | $45.45 | 13.72K |
| Q1 2016 | share | Increase | +9.56% | 785 shares | -108K | $39.55 | 8.99K |